| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 04/05/2000 | EP0989847A1 Anti-tumoral therapy agent |
| 04/05/2000 | EP0989846A2 Non-irritating cosmetic and pharmaceutical compositions |
| 04/05/2000 | EP0989845A1 Topical administration of catecholamines and related compounds to subcutaneous muscle tissue using percutaneous penetration enhancers |
| 04/05/2000 | EP0989805A1 Nucleic acid sequences for atp-binding cassette transporter |
| 04/05/2000 | EP0874812B1 Novel 2,3,5-trimethyl-4-hydroxy anilide derivatives, preparation thereof and therapeutical use thereof |
| 04/05/2000 | EP0871608B1 Monofunctionalised EDTA-, DTPA- and TTHA-Derivatives and their use for the preparation of a diagnoctic or therapeutic medicine |
| 04/05/2000 | EP0777672A4 Amino acid chelates having improved palatability |
| 04/05/2000 | EP0766664B1 Metalloproteinase inhibitors |
| 04/05/2000 | EP0765308B1 Enzyme inhibitors |
| 04/05/2000 | EP0738147B1 Application of riluzole in the treatment of mitochondrial diseases |
| 04/05/2000 | EP0734371B1 Novel retinoid conjugate compounds and methods for treating skin aging |
| 04/05/2000 | EP0716661B1 Pseudo- and non-peptide bradykinin receptor antagonists |
| 04/05/2000 | EP0670719B1 Combination of atovaquone with proguanil for the treatment of protozoal infections |
| 04/05/2000 | EP0656361B1 Autoimmune disease treating drug |
| 04/05/2000 | EP0595873B1 Cytosine deaminase negative selection system for gene transfer techniques and therapies |
| 04/05/2000 | CN1249780A CASH (caspase homologue) with death effector domain, modulators of function of FAS receptors |
| 04/05/2000 | CN1249753A Farnesyl transferase inhibiting 1,8-annelated quinolinone derivs. substd. with N- or C-linked imidazoles |
| 04/05/2000 | CN1249751A Substd. 2,4-diaminopyrimidines |
| 04/05/2000 | CN1249750A Crystalline hydrated sodium salt of (E)-4,6-dichloro-3-(2-oxo-1-phenylpyrrolidin-3-ylidene methyl)-1H-indole-2-carboxylic acid |
| 04/05/2000 | CN1249749A Phthalazinones |
| 04/05/2000 | CN1249748A Small molecules useful in treatment of inflamatory disease |
| 04/05/2000 | CN1249745A Vitronectin receptor antagonists |
| 04/05/2000 | CN1249744A Nitric oxide synthase inhibitors |
| 04/05/2000 | CN1249743A Arylsulfonylamino hydroxamic acid derivs |
| 04/05/2000 | CN1249742A Anti-inflammatory compounds |
| 04/05/2000 | CN1249689A Stable solid preparation contg. vitamin D3 and tricalcium phosphate |
| 04/05/2000 | CN1249688A Self-regulated apoptosis of inflammatory cells by gene therapy |
| 04/05/2000 | CN1249687A Compositions and methods for reducing ocular hypertension |
| 04/05/2000 | CN1249686A Paroxetine compositions |
| 04/05/2000 | CN1249685A Use of levobupivacaine or ropivacaine in treating migraine |
| 04/05/2000 | CN1249684A Use of levobupivacaine in facial surgery |
| 04/05/2000 | CN1249683A Use of leveobupivacaine in paediatric surgery |
| 04/05/2000 | CN1249682A Use of angiotension II antagonists to treat symptomatic heart failure |
| 04/05/2000 | CN1249681A N-oxides of heterocyclic esters, amides, thioesters, and ketones |
| 04/05/2000 | CN1249680A Diabetes remedies |
| 04/05/2000 | CN1249679A Transdermal therapeutic system |
| 04/05/2000 | CN1249309A Gentianate of macrolides antibiotics |
| 04/05/2000 | CN1249308A Compound extracted from heroubill herb and its medicinal preparation |
| 04/05/2000 | CN1249304A Implementation of red shift using organic sulfur compound in ultraviolet/visible light absorption band of carotenoid |
| 04/05/2000 | CN1249181A Universal medicinal cream and its preparing process |
| 04/05/2000 | CN1249178A Puerrarin injection for perfusion and its preparing process |
| 04/05/2000 | CN1249177A Activator administration system contg. composition based on salicylic deriv. in film structure, and its use |
| 04/05/2000 | CN1051110C Method and related reagent box for sieve examination of leukemia and its tissue |
| 04/05/2000 | CN1051096C Oligomers, their uses and formulations |
| 04/05/2000 | CN1051090C Ganglioside GM3 analog having sialic acid residue fluorinated at 9-position |
| 04/05/2000 | CN1051086C Heterocycle-condensed morphinoid derivs. and use thereof |
| 04/05/2000 | CN1051085C Substed. dihydropyranopyridines, their preparation process, use and pharmaceutical composition contg. same |
| 04/05/2000 | CN1051084C Preparation of N-9 substd. guanine compounds |
| 04/05/2000 | CN1051083C Novel substd. puriny derivs. with immunomodulating activity |
| 04/05/2000 | CN1051082C Baccatine III derivs. and their preparation method |
| 04/05/2000 | CN1051081C Method for preparing inclusion complexes of 3-morpholino-sydnonimine |
| 04/05/2000 | CN1051080C Method for preparing pharmaceutical composition contg. substd. sydnonimine or salts |
| 04/05/2000 | CN1051079C Benzodiazepine derivs. their preparation method and pharmaceutical composition contg. same |
| 04/05/2000 | CN1051077C Process for preparing benzo [C] phenanthridine derivs. |
| 04/05/2000 | CN1051074C Use of isoxazole-4-carboxamides and hydroxyalkylidenecyanoacetamides for preparing medicine |
| 04/05/2000 | CN1051016C Liver protecting and sobering preparation and its preparing method |
| 04/05/2000 | CN1051000C Health-care product capable of reducing fat |
| 04/05/2000 | CN1050996C Treatment of chemotherapeutic agent and antiviral agent toxicity with acylated pyrimidine |
| 04/05/2000 | CN1050995C Elaboration of host defense mediators into biological fluids by systemic ds RNA treatment |
| 04/05/2000 | CN1050994C Enteroclysis medicine liquid for treating diarrhea |
| 04/05/2000 | CN1050993C Drug with effect of resisting and preventing tension and intelligence promoting |
| 04/04/2000 | US6046355 Dihydropyrones with improved antiviral activity |
| 04/04/2000 | US6046341 An active drug having affinity for vasopressin and/or oxytocin receptors |
| 04/04/2000 | US6046340 Imidazole containing pseudodipeptide product and compositions containing the same |
| 04/04/2000 | US6046334 Heterocyclic chemical compound |
| 04/04/2000 | US6046331 Imidazolones and their use in treating benign prostatic hyperplasia and other disorders |
| 04/04/2000 | US6046329 Uracil derivatives |
| 04/04/2000 | US6046328 Combination preparation, containing cyclosporin A or FK506 or rapamycin and a xanthine derivative |
| 04/04/2000 | US6046319 Antisense oligodeoxynucleotides regulating expression of TNF-α |
| 04/04/2000 | US6046313 Process for making morphine-6-glucuronide or substituted morphine-6-glucuronide |
| 04/04/2000 | US6046244 Composition comprising prostaglandin e1, skin penetration enhancer, polysaccharide gum, lipophilic compound, acidic buffer system |
| 04/04/2000 | US6046242 Use of aryl-substituted cyclobutylalkylamines for treating urinary incontinence |
| 04/04/2000 | US6046241 Administering to a mammal beta-alethine, or salt, to treat the non-hematolymphoid neoplasia |
| 04/04/2000 | US6046240 Methods for treating female sexual dysfunction |
| 04/04/2000 | US6046239 Used in the treatment of disorders associated with smooth muscle contraction, via potassium channel and chloride channel modulation such as urinary incontinence, asthma, angina, premature labor, congestive heart failure |
| 04/04/2000 | US6046238 Method for treating or preventing the spread of acne vulgaris |
| 04/04/2000 | US6046237 Non-β-oxidizable fatty acid analogues, their uses as therapeutic active medicaments |
| 04/04/2000 | US6046236 Carbocyclic sulfonamides |
| 04/04/2000 | US6046234 Formulations and methods of reducing toxicity of antineoplastic agents |
| 04/04/2000 | US6046233 Agent for treating cor pulmonale |
| 04/04/2000 | US6046232 α-aryl-N-alkylnitrones and pharmaceutical compositions containing the same |
| 04/04/2000 | US6046231 Administering a sufficient amount of a cancer chemopreventative composition comprising 4'-bromoflavone to a mammal in need to prevent, delay or reverse a cancer sensitive to 4'-bromoflavone |
| 04/04/2000 | US6046230 Stable injection formulation containing paclitaxel |
| 04/04/2000 | US6046228 Include 1,2-dithiane and 1,2 dithiolane compounds, the ring sulfur atoms may be present in the sulfur oxide or sulfone state, useful for inhibiting retrovirus replication |
| 04/04/2000 | US6046227 Useful in the treatment of type ii diabetes and obesity; a substituted pyrazine compound |
| 04/04/2000 | US6046226 Administering to a patient an anti cryptococcus neoformans using dicationic bis/benzimidazole compounds; antifungal agents |
| 04/04/2000 | US6046224 12 (S)--hete receptor blockers |
| 04/04/2000 | US6046223 Treatment of macular edema |
| 04/04/2000 | US6046222 Preventing or delaying the noninsulin dependent diabetes mellitus comprising administering to a host suffering from polycystic ovary syndrom or suffered from gestational diabetes a therapeutically effective amount of pioglitazone |
| 04/04/2000 | US6046221 Useful for reducing levels of tumor necrosis factor-alpha in a mammal |
| 04/04/2000 | US6046220 Propynyl or dienyl biaromatic compounds |
| 04/04/2000 | US6046219 Administering to the patient for treating the conditions mediated by collagen formation together with cell proliferation a hydroxypyridine derivative |
| 04/04/2000 | US6046216 Method of treating a patient having precancerous lesions with phenyl pyridinone derivatives |
| 04/04/2000 | US6046215 A piperidinylbenzothiophenes useful for trating brain disorders |
| 04/04/2000 | US6046213 Neuroprotective 3-(piperidinyl-1)-chroman-4,7-diol and 1-(4-hydroxyphenyl)-2-(piperidinyl-1)-alkanol derivatives |
| 04/04/2000 | US6046212 Antiallergic agents |
| 04/04/2000 | US6046211 Amidino derivatives useful as nitric oxide synthase inhibitors |
| 04/04/2000 | US6046210 Antipsychotic agents |
| 04/04/2000 | US6046206 Method of treating a patient having a precancerous lesions with amide quinazoline derivatives |
| 04/04/2000 | US6046205 For treatment of venous insufficiency and of associated disorders, and also in the treatment of migraine |